NCT01716026

Initial Treatment With Bevacizumab in Choroidal Neovascularization Associated to High Myopia

Establishment of the Initial Protocol With Intravitreal Bevacizumab for the Treatment of Choroidal Neovascularization Associated With High Myopia:3 vs 1.

• Status: Completed
• Phase: Phase 3
• Study type: Interventional
• Enrollment: 66 (actual)
• Sponsor: Instituto Universitario de Oftalmobiología Aplicada (Institute of Applied Ophthalmobiology) - IOBA · Academic / Other
• Sex: All
• Age: 18 Years
• Healthy volunteers: Not accepted

Summary

The purpose of this protocol is to determine wether the initial protocol in the treatment of subfoveal choroidal neovascularization associated to High Myopia with bevacizumab intravitreal injections is more effective when using 3 doses vs using 1 single dose in the load period

Conditions

• Choroidal Subfoveal/Juxtafoveal Neovascularization in High Myopia

Interventions

Type	Name	Description
DRUG	Bevazizumab intravitreal injection	Intravitreal injection of bevacizumab

Timeline

• Start date: 2012-10-01
• Primary completion: 2018-04-01
• Completion: 2018-04-01
• First posted: 2012-10-29
• Last updated: 2023-03-13

Locations

11 sites across 1 country: Spain